sur AI/ML Innovations Inc. (isin : CA00143Y1034)
AI/ML Innovations Inc. Welcomes Dr. Alan Rabinowitz as CMO
AI/ML Innovations Inc. has appointed Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships. A renowned cardiologist and healthcare innovator, Dr. Rabinowitz will guide AI/ML's AI-driven healthcare solutions. He brings over 20 years of experience in clinical cardiology and healthcare strategy.
Dr. Rabinowitz held the position of Director at St. Paul's Hospital's Coronary Care Unit and is a Clinical Associate Professor at the University of British Columbia. His background includes leading ventures in advanced diagnostics and personalized medicine, integrating AI with cardiology for improved patient care.
Paul Duffy, CEO of AI/ML, applauded Dr. Rabinowitz's vision in cardiology and digital health. Mark Orsmond, Executive Chairman, emphasized the strategic role Dr. Rabinowitz will play in the company's digital health ambitions.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AI/ML Innovations Inc.